手部和足部肿瘤切除患者使用三维打印定制假体的MSTS评分与并发症如何
这项回顾性研究纳入11例手或足部肿瘤切除后使用三维打印定制假体重建的患者,中位随访47个月,中位MSTS评分为30分中28分,7例出现术后并发症,5年假体断裂和再手术的Kaplan-Meier累积发生率分别为35%和29%。作者认为三维打印假体可能是手足大块骨与关节缺损重建的一种选择,但并发症和再手术频繁,未来需与植骨或骨水泥进行比较。
要点
- 11例手或足部肿瘤患者切除后使用三维打印定制假体,中位MSTS评分为30分中28分。
- 7/11例发生术后并发症,包括超伸畸形和关节僵硬3例、关节半脱位2例、无菌性松动1例、柄断裂1例、钢板断裂1例。
- 5年假体断裂和再手术的Kaplan-Meier累积发生率分别为35%(95%CI 6%至69%)和29%(95%CI 3%至66%)。
核心结论
- 这些初步发现提示,三维打印假体可能是手部和足部大块骨与关节缺损切除后重建的一种选择。
- 尽管功能结果总体看来良好至优秀,但并发症和再手术频繁;因此作者认为,当患者除截肢外几乎没有或没有其他选择时,可考虑该方法。
- 未来研究需要将该方法与植骨或骨水泥进行比较。
研究设计与样本
- 回顾性研究,纳入2017年1月至2020年10月期间治疗的276例手或足部肿瘤患者中,经筛选后11例接受肿瘤切除和三维打印定制假体重建的患者进行分析。
- 11例中女性7例、男性4例,中位年龄29岁(范围11至71岁);手部肿瘤5例、足部肿瘤6例。
- 肿瘤类型为骨巨细胞瘤5例、软骨母细胞瘤2例、骨肉瘤2例、神经内分泌肿瘤1例、鳞状细胞癌1例;切除后边缘状态≥1 mm。
- 所有患者随访至少24个月,中位随访时间47个月(范围25至67个月)。
- 功能采用肌肉骨骼肿瘤协会(MSTS)、DASH和美国骨科足踝协会评分评估;假体断裂和再手术的累积发生率采用Kaplan-Meier分析。
主要发现
- 中位MSTS评分为30分中28分(范围21至30)。
- 11例中7例发生术后并发症,主要包括超伸畸形和关节僵硬(3例)、关节半脱位(2例)、无菌性松动(1例)、柄断裂(1例)和钢板断裂(1例),但未发生感染或局部复发。
- 2例手部患者的掌指关节和近端指间关节半脱位由假体设计无关节或柄所致,这些假体被翻修为带关节和柄的第二代假体,灵活性改善。
- Kaplan-Meier分析中,5年假体断裂的累积发生率为35%(95%CI 6%至69%),再手术的累积发生率为29%(95%CI 3%至66%)。
关键数值与推荐
- 中位MSTS评分为30分中28分(范围21至30)。
- 5年假体断裂的Kaplan-Meier累积发生率为35%(95%CI 6%至69%)。
- 5年再手术的Kaplan-Meier累积发生率为29%(95%CI 3%至66%)。
- 11例中7例发生术后并发症。
临床怎么用
- 作者认为,当患者除截肢外几乎没有或没有其他选择时,可考虑使用三维打印定制假体进行手部和足部大块骨与关节缺损的重建。
- 作者指出未来研究需要将该方法与植骨或骨水泥进行比较。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are a few good options for restoring bone defects in the hand and foot. 3D-printed implants have been used in the pelvis and elsewhere, but to our knowledge, they have not been evaluated in the hand and foot. The functional outcome, complications, and longevity of 3D-printed prostheses in small bones are not well known. QUESTIONS/PURPOSES: (1) What are the functional outcomes of patients with hand or foot tumors who were treated with tumor resection and reconstruction with a 3D-printed custom prosthesis? (2) What complications are associated with using these prostheses? (3) What is the 5-year Kaplan-Meier cumulative incidence of implant breakage and reoperation? METHODS: Between January 2017 and October 2020, we treated 276 patients who had tumors of the hands or feet. Of those, we considered as potentially eligible patients who might have extensive loss in their joint that could not be fixed with a bone graft, cement, or any prostheses available on the market. Based on this, 93 patients were eligible; a further 77 were excluded because they received nonoperative treatment such as chemoradiation, resection without reconstruction, reconstruction using other materials, or ray amputation; another three were lost before the minimum study follow-up of 2 years and two had incomplete datasets, leaving 11 for analysis in this retrospective study. There were seven women and four men. The median age was 29 years (range 11 to 71 years). There were five hand tumors and six tumors of the feet. Tumor types were giant cell tumor of bone (five), chondroblastoma (two), osteosarcoma (two), neuroendocrine tumor (one), and squamous cell carcinoma (one). Margin status after resection was ≥ 1 mm. All patients were followed for a minimum of 24 months. The median follow-up time was 47 months (range 25 to 67 months). Clinical data; function according to the Musculoskeletal Tumor Society, DASH, and American Orthopedic Foot and Ankle Society scores; complications; and survivorship of implants were recorded during follow-up in the clinic, or patients with complete charts and recorded data were interviewed on the telephone by our research associates, orthopaedic oncology fellows, or the surgeons who performed the surgery. The cumulative incidence of implant breakage and reoperation was assessed using a Kaplan-Meier analysis. RESULTS: The median Musculoskeletal Tumor Society score was 28 of 30 (range 21 to 30). Seven of 11 patients experienced postoperative complications, primarily including hyperextension deformity and joint stiffness (three patients), joint subluxation (two), aseptic loosening (one), broken stem (one), and broken plate (one), but no infection or local recurrence occurred. Subluxations of the metacarpophalangeal and proximal interphalangeal joints in two patients' hands were caused by the design of the prosthesis without a joint or stem. These prostheses were revised to a second-generation prosthesis with joint and stem, leading to improved dexterity. The cumulative incidence of implant breakage and reoperation in the Kaplan-Meier analysis was 35% (95% CI 6% to 69%) and 29% (95% CI 3% to 66%) at 5 years, respectively. CONCLUSION: These preliminary findings suggest that 3D implants may be an option for reconstruction after resections that leave large bone and joint defects in the hand and foot. Although the functional results generally appeared to be good to excellent, complications and reoperations were frequent; thus, we believe this approach could be considered when patients have few or no alternatives other than amputation. Future studies will need to compare this approach to bone grafting or bone cementation. LEVEL OF EVIDENCE: Level IV, therapeutic study.
引用
- Chandhanayingyong C, Thanapipatsiri P, Pairojboriboon S, et al. What Are the MSTS Scores and Complications Associated With the Use of Three-dimensional Printed, Custom-made Prostheses in Patients Who Had Resection of Tumors of the Hand and Foot? Clin Orthop Relat Res. 2023. PMID: 37339168. doi:10.1097/CORR.0000000000002730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。